FeLV in Egypt: limited evidence on infection and cancer in cats
Infectious agents and cancer · 2025
In plain language
A 2025 review states that progressive FeLV disease can cause cancer in the tissues that produce blood cells in domestic cats. It describes a Cairo study in which 8 of 174 feral cats tested positive for FeLV, reported as 4.6%. That finding does not show how many cats had cancer or progressive infection, and it does not represent all cats in Egypt. The local studies summarized do not establish which FeLV subtypes circulate in the country.
Scientific detail
The 2025 review “Virological perspectives of the current situation of oncogenic viruses in Egypt: a review,” published in Infectious agents and cancer (doi: 10.1186/s13027-025-00706-7), covers multiple species. It reports neither an original study cohort nor the total number of studies reviewed. Drawing on cited literature, its FeLV section states that progressive FeLV disease in domestic cats can cause hematopoietic neoplasia. This is not a new experimental finding. The supplied object assigns this claim evidence level C; the passage does not quantify lymphoma or leukemia risk, identify tumor lineages, or establish the molecular mechanism.
The review reports FeLV seropositivity in 8 of 174 feral cats tested in Cairo, reported as 4.6%. Although the source calls this percentage “incidence,” it describes a seroprevalence study, so the finding should not be interpreted as longitudinal incidence. This claim is also assigned evidence level C. The result does not measure cancer occurrence, progressive infection, or national prevalence. The supplied text does not include the underlying feline study’s methods, control information, assay details, or uncertainty estimates.
The authors explicitly note the limited Egyptian FeLV prevalence data and the absence of further subtyping in the cited local research. Circulating subtypes remain an open question; the review identifies molecular investigation as necessary to determine them. It does not establish the local burden of FeLV-associated lymphoma or leukemia, subtype-specific tumor risks in Egyptian cats, or a FeLV-specific molecular oncogenesis mechanism demonstrated in those cats.
Within its broader discussion of oncoviruses, the review also states that quantitative estimates of annual economic losses in Egypt’s poultry and animal sectors are unavailable.
What we know
The review states that progressive FeLV disease can cause hematopoietic neoplasia in domestic cats and reports seropositivity in 8 of 174 feral cats in Cairo, reported as 4.6%. Both claims are assigned evidence level C in the supplied object and come from cited literature, not new experiments conducted for the review. The seropositivity finding does not measure cancer, progressive infection, or national prevalence.
What we don't know
The local research summarized does not determine which FeLV subtypes circulate in Egypt, the local burden of FeLV-associated lymphoma or leukemia, or subtype-specific tumor risks. Nor does it demonstrate a FeLV-specific molecular oncogenesis mechanism in those cats. The supplied text lacks the cited feline study’s methods, control information, assay details, and uncertainty estimates. The review does not report the total number of studies reviewed and notes that quantitative annual economic-loss estimates for oncoviruses in Egypt’s poultry and animal sectors are unavailable.
Evidence
EvidenceLevel C — Preliminary evidenceConfidence 100/100
The review states that progressive FeLV disease in domestic cats can cause hematopoietic neoplasia.
Excerpt verified in the source — verbatim, in the source's own language“FeLV infection in domestic cats is considered a significant cause of death due to its ability to cause bone marrow disorders, immune suppression, and hematopoietic neoplasia with the progressive form of the disease [ 20 ].”
This is a feline-specific statement summarized from cited literature, not a new experimental result. The passage does not quantify lymphoma or leukemia risk, identify tumor lineages, or establish the molecular mechanism. Level C is a conservative assignment because the supplied review does not expose the underlying study design or controls.
EvidenceLevel C — Preliminary evidenceConfidence 100/100
The review reports FeLV seropositivity in 8 of 174 feral cats tested in Cairo, reported as 4.6%.
Excerpt verified in the source — verbatim, in the source's own language“In Egypt, a seroprevalence study in Cairo found that only 8 of 174 feral cats tested were seropositive for FeLV, resulting in an incidence of 4.6% [ 36 ].”
The source describes a seroprevalence study but calls the percentage an incidence. This extraction retains the reported count and percentage without treating them as longitudinal incidence. The finding does not measure cancer occurrence, progressive infection, or national prevalence. The underlying study's methods and controls are not supplied.
Open questionConfidence 100/100
Which FeLV subtypes circulate in Egypt remains unresolved in the local research summarized by the review.
The FeLV section explicitly states that previous research focused on seroprevalence without further subtyping and identifies molecular investigation as necessary to determine circulating subtypes. It does not establish which subtypes are present or their contributions to feline lymphoma and leukemia in Egypt.
Provenance
Source: Virological perspectives of the current situation of oncogenic viruses in Egypt: a review.
AVA